Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-07-22Clinical Trial Update: Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients [Phase 2]
A Phase 2 clinical trial comparing three-dimensional conformal radiotherapy (3-D RT) with intensity-modulated radiotherapy (IMRT) for patien…
-
CLINICAL_TRIALS withdrawal · 2016-07-22Clinical Trial Update: Male Stress Urinary Incontinence and Sexual Health
A Stanford University-sponsored clinical trial investigating male stress urinary incontinence and sexual health in prostate cancer patients …
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes [Phase 1]
Phase 1 clinical trial evaluating indocyanine green–based fluorescence imaging to localize prostate cancer and metastatic lymph nodes.
-
CLINICAL_TRIALS research · 2016-07-21Clinical Trial Update: Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer [Phase 3]
This clinical trial update describes a Phase 3 study of combination hormone therapy followed by radiation therapy for prostate cancer. The c…
-
CLINICAL_TRIALS research · 2016-07-19Clinical Trial Update: Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels [Phase 2]
Phase 2 trial evaluating a soy protein supplement to prevent prostate cancer in men with elevated PSA levels has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer [NA]
This ClinicalTrials.gov entry reports a completed study evaluating magnetic resonance spectroscopy in localized prostate cancer. The trial d…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer [Phase 2]
This clinical trial update indicates a Phase 2 study evaluating adding androgen suppression to radiation therapy for prostate cancer has com…
-
FDA approval · 2016-07-15FDA Approved: NILUTAMIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for the generic drug nilutamide.
-
FDA approval · 2016-07-14FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) filed by Astellas Pharma US, Inc.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
This Phase 2 trial evaluated combination chemotherapy plus filgrastim in patients with stage IV prostate cancer that progressed after hormon…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
This clinical trial update reports on a study examining gene mutations in patients with advanced hormone-refractory prostate cancer. The tri…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer [Phase 2]
This Phase 2 trial update summarizes the results of using hormone therapy followed by internal radiation therapy in patients with locally re…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis [Phase 3]
Phase 3 trial evaluating octreotide to prevent diarrhea in patients receiving pelvic radiotherapy across multiple pelvic cancers has complet…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer [Phase 3]
This Phase 3 trial evaluates whether adding dalteparin to standard therapy improves outcomes in patients with advanced breast, lung, colorec…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Lycopene in Treating Patients With Metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating lycopene in patients with metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
A Phase 2 clinical trial update on Nitrocamptothecin for stage IV prostate cancer that progressed after hormone therapy (study completed).
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate [Phase 2]
Phase 2 clinical trial update on flutamide for prevention of prostate cancer in patients with neoplasia of the prostate; the trial status is…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 clinical trial evaluating green tea extract in patients with metastatic prostate cancer that has not responded to hormone therapy ha…
-
CLINICAL_TRIALS withdrawal · 2016-07-13Clinical Trial Update: Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence [Phase 2]
A Phase 2 trial evaluating mitoxantrone after surgery in high-risk prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy [Phase 3]
A Phase 3 randomized trial comparing immediate versus deferred androgen deprivation therapy with goserelin for recurrent prostate cancer aft…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer [Phase 1]
A Phase 1 clinical trial evaluated a MUC1 vaccine in combination with Poly-ICLC in patients with recurrent or advanced prostate cancer. The …
-
CLINICAL_TRIALS withdrawal · 2016-07-12Clinical Trial Update: Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating docetaxel in combination with St. John's Wort for solid tumors that cannot be removed surgically has been withdra…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes [NA]
A completed randomized trial comparing two different prostate biopsy schemes, assessing diagnostic approaches in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Surgery in Treating Patients With Prostate Cancer [Phase 2]
A Phase 2 trial evaluating surgery as a treatment for prostate cancer has completed. The update reflects the completion status of the study …
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer [Phase 3]
A Phase 3 trial comparing surgery versus internal radiation for Stage II prostate cancer has completed; results are not detailed in the prov…